Meeting
2017 ASCO Annual Meeting
Detection of tumor-derived DNA mutations in cerebrospinal fluid of patients with primary or metastatic brain tumors.
Authors
Jianfei Wang
Genecast Precision Medicine Technology Institute, Beijing, China
Jianfei Wang , Wenbo Han , Chen Tian , Ying Hu , Yanhui Chen , Xiangru Li , Ruihan Guo , Haibo Wang , Henghui Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2070)
DOI
10.1200/JCO.2017.35.15_suppl.2070
Abstract #
2070
Poster Bd #
312
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
NGS to reveal heterogeneity between cerebrospinal fluid and plasma ctDNA among non-small cell lung cancer patients with leptomeningeal carcinomatosis.
First Author: Ben-Yuan Jiang
Poster
2023 ASCO Annual Meeting
ctDNA detection in patients with brain metastases arising from solid tumors.
First Author: Laura Alder
Poster
2023 ASCO Annual Meeting
Does serial circulating tumor DNA (ctDNA) monitoring identify additional acquired actionable alterations in metastatic colorectal cancer (mCRC)?
First Author: Jonathan M. Loree
Poster
2022 ASCO Annual Meeting
Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and to better predict intracranial tumor response in patients with non–small cell lung cancer with brain metastases: A prospective cohort study.
First Author: Meichen Li